Role evaluation of autoimmune inflammatory reaction in cerebral ischemia pathogenesis
Neurology Bulletin · 2003
DOI: 10.17816/nb100104 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurology Bulletin, 2003. Verfasst von G. N. Zhdanov und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
Monitoring of contents of antibodies to deoxyribonucleic acid in cerebrospinal fluid and in blood serum at dynamics of acute ischemic insult has been done. It was noticed a reliable increase of antibody level to deoxyribonucleic acid during the first 24 hours of cerebral ischemia both in the blood serum and in the cerebrospinal fluid. Increase is shown untill the 10th day, and then there is a decrease. It should be noted that the higher antibody levelis the more neurology deficit is expressed and the prognosis is worse. The performed clinical and immunologic study confirmed a role of autoimmune reactions and caused by them a local inflammation in pathogenesis of ischemic insult and infarction alterations formations in the brain tissue.
Zitieren
APA
Zhdanov, G. N., & Gerasimova, M. M. (2003). Role evaluation of autoimmune inflammatory reaction in cerebral ischemia pathogenesis. Neurology Bulletin. https://doi.org/10.17816/nb100104
Vancouver
Zhdanov GN, Gerasimova MM. Role evaluation of autoimmune inflammatory reaction in cerebral ischemia pathogenesis. Neurology Bulletin. 2003. doi:10.17816/nb100104
BibTeX
@article{Zhdanov2003,
author = {Zhdanov, G. N. and Gerasimova, M. M.},
title = {Role evaluation of autoimmune inflammatory reaction in cerebral ischemia pathogenesis},
journal = {Neurology Bulletin},
year = {2003},
doi = {10.17816/nb100104}
}
EUVIMED